Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Vascular Neurology
•
Endocrinology
•
Transgender Care
•
Male and Female Reproductive Disorders
What estradiol patch dose do you recommend for transgender adult patients with prior history of stroke or myocardial infarction?
Related Questions
What is your preferred imaging modality for determining infarct core when evaluating acute stroke cases?
How should PCOS be addressed after menopause?
In an obese male with low testosterone, would you initiate testosterone replacement therapy at the initial visit, or start tirzepatide first and monitor for improvement in testosterone levels and erectile function?
Is long-term medical management effective for ovarian hyperthecosis, or is surgery the primary treatment option?
Is abnormally elevated estradiol an expected finding in patients with PCOS?
Would you recommend transdermal estrogen for functional hypothalamic amenorrhea despite recent findings showing no vascular or psychological benefits after 12 weeks?
What patient profiles or clinical contexts would justify the initiation of elinzanetant (Lynkuet) for postmenopausal vasomotor symptoms, considering its mechanism and current evidence base?
How safe and effective is carotid stenting in carotid dissection?
What is your approach to counseling older patients and their families regarding expected recovery of aphasia following a large hemispheric stroke?
Would you consider IV thrombolytics in patients with acute ischemic stroke, with or without a large vessel occlusion, if they have a history of von Willebrand disease (VWD), regardless of its type?
